Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04661137
Title A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hackensack Meridian Health
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center RECRUITING Washington District of Columbia 20007 United States Details
John Theurer Cancer Center RECRUITING Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field